• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Lexicon Opens Path to $1B+ Opportunity as FDA Greenlights Phase

    BIOSPACE

    Lexicon Pharma Gets Positive FDA EOP2 for Pilavapadin in DPN Pain

    GLOBENEWSWIRE

    Lexicon Presents Pilavapadin Data in Peripheral Neuropathy

    GLOBENEWSWIRE

    Lexicon Supports Ph III Go Decision for Non-Opioid Pain Med

    BIOSPACE

    Pilavapadin Shows Significant Pain Relief in Adults

    GLOBENEWSWIRE

    Lexicon Pharma to Share More Pilavapadin Clinical Data at Meeting

    GLOBENEWSWIRE

    Lexicon Presents Diabetic Neuropathic Pain at PAINWeek

    GLOBENEWSWIRE

    Lexicon Ph2b Study Shows Pilavapadin Benefit In Diabetic Pain

    GLOBENEWSWIRE

    Lexicon Pharma To Release Ph 2b Results For Diabetic Neuropathic Pain

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.